Research Antibodies Market Is Predicted To Grow Swiftly Due To Growing Stem Cells & Neurobiology Research Till 2025: Grand View Research, Inc.


The global research antibodies market size is expected to reach USD 4.30 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% during the forecast period. The market is predominantly driven by growing number of R&D collaborations among various public and private organizations to promote technical advancements in product development activities and disease progression studies. Consistent recommendations and guidelines issued by regulatory organizations for laboratories to facilitate generation of accurate results and ensure high-quality standards are slated to enhance adoption of research antibodies over the coming years. For instance, in May 2016, the International Society for Stem Cell Research issued revised guidelines for cell-based therapies. The revised guidelines were issued with a focus to improve overall efficiency and quality of preclinical studies.




In addition, prominent market players are entering into partnership with R&D entities that are anticipated to open new avenues. In December 2016, Bayer AG and Versant Ventures collaborated to invest around USD 225.0 million for the establishment of a stem cell research facility in Canada to encourage commercialization of regenerative medicine therapies. Increasing prevalence of breast cancer and soaring need for personalized medicine is stirring up the demand for advanced techniques, which in turn is creating ample growth opportunities for the research antibodies market.

Browse full research report on Research Antibodies Market: www.grandviewresearch.com/industry-analysis/research-antibodies-market   

Further key findings from the study suggest:            
         
  • Primary antibodies were the most prominent product segment in 2016 owing to greater specificity leading to increased adoption in research activities. The segment is expected to account for more than 65.0% of the overall market revenue by 2025
  • On the basis of type, monoclonal antibodies captured substantial share of the market in 2016, owing to high sensitivity for detection of antigens and efficient staining properties with less background noise. The segment is anticipated to rise at a CAGR of 6.6% during the forecast period
  • Western blotting commanded the leading share in the market, due to benefits such as better immunogenic response from infectious agents and higher cost efficiency. The immunoprecipitation segment is estimated to post the highest CAGR of just over 7.0% during the same period
  • Mouse antibodies are relatively easier to produce and possess greater specificity, thus resulting in higher adoption in R&D and accounting for the largest market share in 2016.
  • Oncology accounted for over 36.0% of the overall revenue in 2016 as a consequence of growing cancer population
  • Pharmaceutical & biotechnology companies will be the leading end users of research antibodies owing to increased adoption in drug development and discovery. The segment is poised to represent more than 61.0% of the overall revenue by 2025.
  • Contract research organizations are likely to be the most promising end-user segment during the forecast period owing to greater cost efficiency
  • North America will continue to be the dominant revenue contributor throughout the forecast period owing to local presence of various biotechnology & biopharmaceutical manufacturers striving to compete in the market
  • Some of the key players in the global arena are Abcam PLC; Agilent Technologies; and Thermo Fisher Scientific, Inc. The research antibodies market is moderately consolidated and highly competitive due to low entry barriers.
Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology                                                                                                                                                              
Grand View Research has segmented the global research antibodies market on the basis of product, type, technology, source, application, end-use, and region:

Research Antibodies Product Outlook (Revenue, USD Million, 2014 - 2025)
  • Primary
  • Secondary
Research Antibodies Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Monoclonal Antibodies
  • Polyclonal Antibodies
Research Antibodies Technology Outlook (Revenue, USD Million, 2014 - 2025)
  • Immunohistochemistry
  • Immunofluorescence
  • Western Blotting
  • Flow Cytometry
  • Immunoprecipitation
  • ELISA
  • Others
Research Antibodies Source Outlook (Revenue, USD Million, 2014 - 2025)
  • Mouse
  • Rabbit
  • Goat
  • Others
Research Antibodies Application Outlook (Revenue, USD Million, 2014 - 2025)
  • Infectious Diseases
  • Immunology
  • Oncology
  • Stem Cells
  • Neurobiology
  • Others
Research Antibodies End-use Outlook (Revenue, USD Million, 2014 - 2025)
  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
Research Antibodies Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S.
    •  Canada
  • Europe
    • U.K.
    •  Germany
  • Asia Pacific
    • Japan
    • China
    •  India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-research-antibodies-market                                                                                                                              
About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, a...
Read more

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Image
The global  hyaluronic acid market   is expected to reach USD 13.4 billion by 2024, according to a new report by Grand View Research. Factors such as increasing concern in population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact-rendering drivers of this market.  The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The growing geriatric population coupled with growing awareness about antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficacy and evident results of hyaluronic acid - based dermal fillers are attracting this population base.  The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis and it is projected that b...
Read more

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.

Image
The global  protein purification and isolation market  is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market.  Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques. U.S. protein purification & isolation market, by technology, 2014 - 2025 (USD Billion) Browse full research report on Protein Purification & Isolation Market: http://www.grandviewresearch.com/industry-analysi...
Read more